Inventor · disambiguated record
Ogari Pacheco
Also filed as: PACHECO OGARI · PACHECO OGARI DE CASTRO
13 granted patents·4 pending applications·9 citations·filing 2002–2019
84Inventor score
Files withCRISTALIA PROD QUIMICOS FARM5CRISTALIA PRODUCTOS QUIMICOS F3CRISTALIA PRODUTOS QUIM FARMACEUTICOS LTDA3PACHECO OGARI2CARVALHO KRISHNAMURTI DE MORAIS1
Top patents by PatentIndex Score
17 records- 0167US7763653B2Ternary and quaternary eutectic mixtures of local anesthetics substancesCRISTALIA PRODUCTOS QUIMICOS F·Filed 2004·Granted Jul 27, 2010·3 cites·9 claims
- 0261US7632853B2Soluble, stable and concentrated pharmaceutical composition compromising ritonavir and process for preparing thereofCRISTALIA PROD QUIMICOS FARM·Filed 2003·Granted Dec 15, 2009·2 cites·14 claims
- 0360US7816409B2Stable pharmaceutical composition of fluoroether compound for anesthetic use method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compoundCRISTALIA PRODUCTOS QUIMICOS F·Filed 2004·Granted Oct 19, 2010·3 cites·27 claims
- 0452US8642258B2Immunogenical complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silicaPACHECO OGARI·Filed 2006·Granted Feb 4, 2014·1 cites·12 claims
- 0551US10081660B2Polynucleotide, polypeptide with immunosuppressive activity, expression cassette, expression vector, host cell, pharmaceutical composition, methods for producing a polypeptide with immunosuppressive activity and for preventing or treating conditions that require immunosuppression, and use of a polypeptideFUND BUTANTAN·Filed 2014·Granted Sep 25, 2018·0 cites·5 claims
- 0650US10597632B2Animal product-free culture medium for bacteria of the genus Clostridium and a process for producing supernatant comprising one or more collagenolytic and gelatinolytic proteasesCRISTALIA PRODUTOS QUIM FARMACEUTICOS LTDA·Filed 2017·Granted Mar 24, 2020·0 cites·12 claims
- 0742US7495105B2Non-racemic mixtures of (S) and (R) enantiomers of N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; related processes and pharmaceutical compositionsCRISTALIA PROD QUIMICOS FARM·Filed 2002·Granted Feb 24, 2009·0 cites·5 claims
- 0841US9725692B2Animal product-free culture medium and a process for producing a supernatant of clostridium comprising one or more collagenolytic and gelatinolytic proteasesCRISTALIA PRODUTOS QUIM FARMAEUTICOS LTDA·Filed 2013·Granted Aug 8, 2017·0 cites·10 claims
- 0941US2009311292A1Process for synthesis and incorporation of nitric oxide donors in macromolecular compositionsCRISTALIA PROD QUIMICOS FARM·Filed 2007·Application pending·0 cites
- 1041US2006217320A1Soft gel formulations for saquinavirCRISTALIA PRODUCTOS QUIMICOS F·Filed 2004·Application pending·0 cites
- 1139US10865209B2Process for preparing temozolomide and an intermediaryCRISTALIA PRODUTOS QUIM FARMACEUTICOS LTDA·Filed 2017·Granted Dec 15, 2020·0 cites·21 claims
- 1237US2015266864A1Heteroaromatic compounds, method for preparing the compounds, pharmaceutical compositions, uses and method for treating acute and chronic painCRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA·Filed 2013·Application pending·0 cites
- 1336US11591243B2Industrial process and system for the inactivation of liquid wasteCRISTALIA PRODUTOS QUIM FARMACEUTICOS LTDA·Filed 2019·Granted Feb 28, 2023·0 cites·23 claims
- 1435US8039678B2Process for the preparation of chloromethyl 2,2,2-trifluoro-1-(trifluoromethyl) ethyl etherCRISTALIA PROD QUIMICOS FARM·Filed 2006·Granted Oct 18, 2011·0 cites·24 claims
- 1535US2010041769A1Stable and ready-to-use oil-in-water propofol microemulsionPACHECO OGARI·Filed 2007·Application pending·0 cites
- 1634US8044247B2Process for the preparation of fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl) ethyl etherCRISTALIA PROD QUIMICOS FARM·Filed 2006·Granted Oct 25, 2011·0 cites·18 claims
- 1718US8541395B2Use of telocinobufagin as an analgesic in the treatment of acute and chronic painsCARVALHO KRISHNAMURTI DE MORAIS·Filed 2010·Granted Sep 24, 2013·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Ogari Pacheco files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →